Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 13Glioblastoma 7Breast Neoplasms 7Brain Neoplasms 7Astrocytoma 7Oligodendroglioma 6Glioma 6Neoplasms 5Gliosarcoma 5Ependymoma 5Thyroid Neoplasms 4Meningioma 4Medulloblastoma 4Lung Neoplasms 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Cancer, Papillary 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neuroectodermal Tumors, Primitive 3Lymphoma 3Hodgkin Disease 3Glioma, Subependymal 3Colorectal Neoplasms 3Colonic Neoplasms 3Adenocarcinoma, Follicular 3Waldenstrom Macroglobulinemia 2Pinealoma 2Optic Nerve Glioma 2Neuroblastoma 2

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 353-Iodobenzylguanidine 34Peripheral Blood Stem Cell Transplantation 31dinutuximab 30Granulocyte Colony-Stimulating Factor 30Radiotherapy 29sargramostim 28Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16naxitamab 15Ifosfamide 15Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole × Clear all
NCT01583842 2021-05-14

124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study

University of California, San Francisco

Phase EARLY_PHASE1 Terminated
10 enrolled
CNS

Neuroblastoma

NCT03013387 2017-08-25

Dosimetry Guided PRRT With 90Y-DOTATOC

University of Iowa

Phase 2 Withdrawn
CNS

Medulloblastoma, Meningioma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡